| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 0 | 34.843 | 57.310 | 63.204 | 99.160 | 60.109 | 224.363 | 193.917 |
| Total Income - EUR | - | - | 0 | 34.843 | 57.310 | 63.217 | 99.411 | 60.109 | 224.363 | 194.150 |
| Total Expenses - EUR | - | - | 133 | 4.771 | 6.628 | 30.738 | 93.223 | 46.815 | 95.089 | 77.587 |
| Gross Profit/Loss - EUR | - | - | -133 | 30.071 | 50.682 | 32.479 | 6.188 | 13.295 | 129.274 | 116.563 |
| Net Profit/Loss - EUR | - | - | -133 | 29.640 | 50.109 | 31.847 | 5.196 | 12.868 | 127.164 | 97.808 |
| Employees | - | - | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Paismedica Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 111 | 109 | 18.028 | 17.569 | 15.636 | 54.046 | 60.683 | 52.541 |
| Current Assets | - | - | 44 | 30.107 | 40.092 | 38.675 | 15.888 | 31.964 | 122.893 | 99.575 |
| Inventories | - | - | 0 | 0 | 0 | 4.552 | 8.001 | 8.026 | 8.059 | 8.589 |
| Receivables | - | - | 0 | 0 | 35.403 | 0 | 0 | 2.932 | 67.955 | 67.602 |
| Cash | - | - | 44 | 8.618 | 4.689 | 3.112 | 7.888 | 11.643 | 37.544 | 14.101 |
| Shareholders Funds | - | - | -221 | 29.425 | 56.838 | 52.876 | 23.999 | 15.648 | 132.865 | 98.820 |
| Social Capital | - | - | 44 | 45 | 44 | 43 | 42 | 43 | 42 | 42 |
| Debts | - | - | 376 | 791 | 1.282 | 3.368 | 7.525 | 70.363 | 50.710 | 53.296 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Paismedica Srl